Sam Brusco, Associate Editor01.24.22
Exactech has acquired a minority interest in JointMedica Limited, a UK-based orthopedic device designer and manufacturer. Together the companies will work together to produce the next generation of hip resurfacing with JointMedica’s Polymotion hip implant.
The device combines proven design principles with a metal-on-polyethylene bearing surface.
“This partnership will bring to market JointMedica’s advanced polyethene hip resurfacing, using Exactech’s global outreach,” Derek McMinn, MD, FRCS, told the press. “Demand for less invasive and less traumatic surgery remains—particularly in younger or more active patients. Our partnership with Exactech will expand on the clinical success of the Birmingham Hip.”
The Polymption hip leverages design principles of previous hip resurfacing devices. It offers hip resurfacing’s biomechanical benefits and eliminates metal-on-metal articulating surfaces.
According to Sharat Kusuma, MD, senior vice president and chief medical officer of Exactech, who has first-hand clinical experience implanting the BHR, “Both Exactech and JointMedica fundamentally understand that hip resurfacing offers significant advantages for specialist hip surgeons and multiple patient groups. Because we are partnering at an early stage, we can incorporate learnings from previous resurfacing market efforts to deliver even greater value to our surgeon partners and their patients.”
The device combines proven design principles with a metal-on-polyethylene bearing surface.
“This partnership will bring to market JointMedica’s advanced polyethene hip resurfacing, using Exactech’s global outreach,” Derek McMinn, MD, FRCS, told the press. “Demand for less invasive and less traumatic surgery remains—particularly in younger or more active patients. Our partnership with Exactech will expand on the clinical success of the Birmingham Hip.”
The Polymption hip leverages design principles of previous hip resurfacing devices. It offers hip resurfacing’s biomechanical benefits and eliminates metal-on-metal articulating surfaces.
According to Sharat Kusuma, MD, senior vice president and chief medical officer of Exactech, who has first-hand clinical experience implanting the BHR, “Both Exactech and JointMedica fundamentally understand that hip resurfacing offers significant advantages for specialist hip surgeons and multiple patient groups. Because we are partnering at an early stage, we can incorporate learnings from previous resurfacing market efforts to deliver even greater value to our surgeon partners and their patients.”
